Bone loss in hepatitis B virus-infected patients can be associated with greater osteoclastic activity independently of the retroviral use

Nucleoside/nucleotide analogs such as tenofovir, have been used as long-term therapy for the treatment of hepatitis B and side effects such as the reduction in bone mineral density have been associated with their use. To determine the relationships between bone, hormonal, biochemical, and mineral pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dessordi, Renata, Watanabe, Ligia Moriguchi, Guimarães, Mariana Palma, Romão, Elen Almeida, de Lourdes Candolo Martinelli, Ana, de Carvalho Santana, Rodrigo, Navarro, Anderson Marliere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119499/
https://www.ncbi.nlm.nih.gov/pubmed/33986322
http://dx.doi.org/10.1038/s41598-021-89486-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119499/
https://www.ncbi.nlm.nih.gov/pubmed/33986322
http://dx.doi.org/10.1038/s41598-021-89486-9

Ejemplares similares